125 related articles for article (PubMed ID: 10192752)
1. Pharmacokinetic evaluation of co-administration of nefazodone and lithium in healthy subjects.
Laroudie C; Salazar DE; Cosson JP; Cheuvart B; Istin B; Girault J; Ingrand I; Decourt JP
Eur J Clin Pharmacol; 1999 Feb; 54(12):923-8. PubMed ID: 10192752
[TBL] [Abstract][Full Text] [Related]
2. Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation.
Barbhaiya RH; Shukla UA; Chaikin P; Greene DS; Marathe PH
Eur J Clin Pharmacol; 1996; 50(1-2):101-7. PubMed ID: 8739819
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.
Barbhaiya RH; Marathe PH; Greene DS; Mayol RF; Shukla UA; Gammans RR; Pittman KA; Robinson D
J Clin Pharmacol; 1995 Oct; 35(10):974-84. PubMed ID: 8568015
[TBL] [Abstract][Full Text] [Related]
4. Carbamazepine-nefazodone interaction in healthy subjects.
Laroudie C; Salazar DE; Cosson JP; Cheuvart B; Istin B; Girault J; Ingrand I; Decourt JP
J Clin Psychopharmacol; 2000 Feb; 20(1):46-53. PubMed ID: 10653208
[TBL] [Abstract][Full Text] [Related]
5. A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses.
Barbhaiya RH; Buch AB; Greene DS
J Clin Psychopharmacol; 1996 Feb; 16(1):19-25. PubMed ID: 8834414
[TBL] [Abstract][Full Text] [Related]
6. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
Barbhaiya RH; Shukla UA; Greene DS; Breul HP; Midha KK
J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
Greene DS; Salazar DE; Dockens RC; Kroboth P; Barbhaiya RH
J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
[TBL] [Abstract][Full Text] [Related]
8. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
Dockens RC; Greene DS; Barbhaiya RH
J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening.
Marathe PH; Lee JS; Greene DS; Barbhaiya RH
Br J Clin Pharmacol; 1996 Jan; 41(1):21-7. PubMed ID: 8824689
[TBL] [Abstract][Full Text] [Related]
10. Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses.
Kaul S; Shukla UA; Barbhaiya RH
J Clin Pharmacol; 1995 Aug; 35(8):830-9. PubMed ID: 8522641
[TBL] [Abstract][Full Text] [Related]
11. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
Barbhaiya RH; Shukla UA; Kroboth PD; Greene DS
J Clin Psychopharmacol; 1995 Oct; 15(5):320-6. PubMed ID: 8830062
[TBL] [Abstract][Full Text] [Related]
12. Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.
Barbhaiya RH; Shukla UA; Greene DS
Br J Clin Pharmacol; 1995 Aug; 40(2):161-5. PubMed ID: 8562300
[TBL] [Abstract][Full Text] [Related]
13. Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan.
Barbhaiya RH; Buch AB; Greene DS
Br J Clin Pharmacol; 1996 Nov; 42(5):573-81. PubMed ID: 8951188
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study.
Khan AY; Preskorn SH; Horst WD
J Pak Med Assoc; 2007 May; 57(5):230-5. PubMed ID: 17571477
[TBL] [Abstract][Full Text] [Related]
15. Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function.
Barbhaiya RH; Brady ME; Shukla UA; Greene DS
Eur J Clin Pharmacol; 1995; 49(3):229-35. PubMed ID: 8666000
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic evaluation during coadministration of nefazodone and propranolol in healthy men.
Salazar DE; Marathe PH; Fulmor IE; Lee JS; Raymond RH; Uderman HD
J Clin Pharmacol; 1995 Nov; 35(11):1109-18. PubMed ID: 8626885
[TBL] [Abstract][Full Text] [Related]
17. The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.
Marino MR; Langenbacher KM; Hammett JL; Nichola P; Uderman HD
J Clin Psychopharmacol; 1997 Feb; 17(1):27-33. PubMed ID: 9004054
[TBL] [Abstract][Full Text] [Related]
18. Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humans.
Marathe PH; Salazar DE; Greene DS; Brennan J; Shukla UA; Barbhaiya RH
Pharm Res; 1995 Nov; 12(11):1716-21. PubMed ID: 8592675
[TBL] [Abstract][Full Text] [Related]
19. Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.
Barbhaiya RH; Shukla UA; Greene DS
Eur J Clin Pharmacol; 1995; 49(3):221-8. PubMed ID: 8665999
[TBL] [Abstract][Full Text] [Related]
20. The lack effect of food on the bioavailability of nefazodone tablets.
Dockens RC; Greene DS; Barbhaiya RH
Biopharm Drug Dispos; 1996 Mar; 17(2):135-43. PubMed ID: 8907720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
